The prediction study of the effect of antibody therapy using antibody dependent cell-mediated cytotoxicity with blood sample

The prediction study of the effect of antibody therapy using antibody dependent cell-mediated cytotoxicity with blood sample - ADCC study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002320

Enrollment

150

Registered

2009-08-11

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: * healthy volunteer(n=20) or * patinets diagnosed as malignant solid tumor with pathology or cytology and * patients who will receive or have already received the antibody therapy

Exclusion criteria

Exclusion criteria: * patients determined ineligible for this study by the researcher

Design outcomes

Primary

Measure	Time frame
the predict of clinical outcome and adverse effect	—

Countries

Japan

Contacts

Public ContactKenji Tamura

national cancer center breast and medical onoclogy division

NCC_IRBoffice@ml.res.ncc.go.jp03-3541-2511

Outcome results